Wernicke Encephalopathy and Alcohol Withdrawal Management

Introduction to Wernicke Encephalopathy and Alcohol Withdrawal

• The European Association for the Study of the Liver and the American Association for the Study of Liver Diseases suggest that Wernicke Encephalopathy (WE) should be considered in any patient with alcohol use disorder who presents with new neurological symptoms or altered mental status, regardless of time elapsed since their last drink 1, 2
• Alcohol withdrawal syndrome typically begins within 6-24 hours after the last drink in alcohol-dependent patients, with initial symptoms including increased blood pressure and pulse rate, tremors, hyperreflexia, irritability, anxiety, headache, nausea, and vomiting, and excessive sweating 3, 4

Diagnosis of Wernicke Encephalopathy

• Neuroimaging, particularly MRI, plays an important role in diagnosis, especially in non-alcoholic WE or atypical presentations, with a high index of suspicion being essential to prevent delays in diagnosis and treatment 1
• The Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) scale is recommended to assess withdrawal severity, with a score >8 indicating moderate withdrawal and a score ≥15 indicating severe withdrawal 3

Treatment and Prevention of Wernicke Encephalopathy and Alcohol Withdrawal

• Immediate thiamine administration is crucial for prevention of WE: 100-300 mg/day for 4-12 weeks, and for management of established WE: 100-500 mg/day for 12-24 weeks, according to the Clinical and Molecular Hepatology guidelines 1
• Thiamine supplementation should be continued for 2-3 months following resolution of symptoms, as recommended by the Clinical and Molecular Hepatology guidelines, and given before glucose-containing fluids to prevent Wernicke's encephalopathy 1, 5
• Benzodiazepines are the gold standard treatment for alcohol withdrawal and should be initiated at the onset of symptoms (6-24 hours after last drink), with symptom-triggered dosing preferred over fixed schedules 3
• Chlordiazepoxide should be administered at a dose of 25-100 mg orally every 4-6 hours as needed, with dosing individualized based on withdrawal severity, and lorazepam (1-4 mg every 4-8 hours) may be considered in patients with advanced age, liver failure, respiratory failure, or other serious medical comorbidities 1, 3
• Alternative medications such as carbamazepine (200 mg every 6-8 hours) may be considered for seizure prevention when benzodiazepines are contraindicated 1

Patient Management and Follow-up

• Patients with liver disease require special attention as they may have impaired thiamine metabolism and storage 3
• Supportive care should include provision of fluids and electrolyte replacement (especially magnesium) and ensuring a comfortable environment 1
• Treatment duration is typically 7-10 days with gradual tapering, and benzodiazepines should be avoided beyond the initial 10-14 days due to potential for abuse 3
• Psychiatric consultation is recommended for evaluation, treatment, and long-term planning of alcohol abstinence, and regular assessment of vital signs and withdrawal symptoms is essential to guide appropriate dosing 1, 3

Special Considerations